|149.41||-6.59 / -4.22%|
Data as of 3:59pm ET
|148.90||-0.51 / -0.34%|
The 24 analysts offering 12-month price forecasts for Celgene Corp have a median target of 190.50, with a high estimate of 241.00 and a low estimate of 141.00. The median estimate represents a +27.50% increase from the last price of 149.41.
The current consensus among 29 polled investment analysts is to Buy stock in Celgene Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.